Remove 2025 Remove FDA Remove Independent Pharmacies
article thumbnail

Independent Pharmacy Wants to Be a “One-Stop Shop for Our Patients”

Drug Topics

Kimberly Jones, RPh, is the pharmacy manager of Austin Pharmacy & Medical Supplies, located in Cockeysville, Maryland, about 25 minutes north of Baltimore. During pharmacy school, my internship was at an independent pharmacy in my hometown, and I realized I preferred that atmosphere,” Jones said. “I

article thumbnail

Meeting Preview: McKesson ideaShare 2025

Drug Topics

McKesson ideaShare 2025 will take place this week in Nashville, Tennessee, and will include educational sessions, keynote sessions, networking events, and hands-on activities. McKesson ideaShare 2025. This year’s conference is taking place from July 10 to 13 in Nashville, Tennessee. REFERENCE McKesson.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves Nitisinone for Treatment of Alkaptonuria

Drug Topics

The FDA approved nitisinone (Harliku) for the reduction of urine homogentisic acid (HGA) in patients with alkaptonuria (AKU). The FDA approved nitisinone (Harliku) for the reduction of urine homogentisic acid (HGA) in patients with alkaptonuria (AKU). The medication is expected to launch in July 2025. June 19, 2025.

FDA
article thumbnail

FDA Approves Insulin Aspart-Xjhz as First Interchangeable Biosimilar to NovoLog

Drug Topics

The FDA approved insulin aspart-xjhz (Kirsty) 100 units/mL as the first and only interchangeable biosimilar to insulin aspart (NovoLog). 1 The FDA approves Kirsty, an interchangeable biosimilar insulin, enhancing diabetes treatment options and accessibility for patients. July 15, 2025. Accessed July 21, 2025.

FDA
article thumbnail

GLP-1s Effective as Adjunctive Therapy in Patients with T1D, Obesity | ADA 2025

Drug Topics

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) were safe and effective as adjunctive therapies for patients with type 1 diabetes (T1D) and overweight or obesity, according to an abstract presented at the American Diabetes Association 85th Scientific Sessions, held in Chicago, Illinois, from June 20-23, 2025.

article thumbnail

How the Rise in US Pharmacy Deserts Impacts Patients’ Health

Drug Topics

More US pharmacies closed than opened in 2018–21; independent pharmacies, those in Black, Latinx communities most at risk. Struggles at CVS, Rite Aid, and Walgreens call into question retail pharmacy’s future. Struggles at CVS, Rite Aid, and Walgreens call into question retail pharmacy’s future. April 28, 2025.

article thumbnail

Collaborative, Pharmacist-Led Approach Crucial in Polypharmacy

Drug Topics

Published online June 29, 2025:100006. Accessed July 18, 2025. A collaborative and patient-centered approach is crucial in improving polypharmacy outcomes, according to a study published in Intelligent Hospital. Optimizing patient care: an inclusive review of polypharmacy and the vital role of pharmacists in mitigation.